IQVIA Holdings Inc. logo
IQVIA Holdings Inc. (IQV)
Compare

IQVIA Holdings Inc. (IQV) Stock Price: $186.25+2.56 (+1.39%)

The total return cagr for IQVIA Holdings Inc. (IQV) stock is 20.84% over the past 12 months. The 3 year average growth rate is -3.40% and the 5 year cagr is -4.90%. Total return includes dividends reinvested.

The closing share price for IQVIA Holdings Inc. (IQV) stock was $186.25 for Tuesday, June 9, 2026, up +1.39% from the previous day.

IQV Price Chart

End-of-day pricesAdvanced chart →
IQV$186.25 18.71%as of Jun 9, 2026

IQV Earnings Preview

Next Earnings Date

Jul 21, 2026

41 days away

EPS Estimate

3.03

Revenue Est.

$4.31B

Last Quarter Results

EPS

$2.90

vs Estimate

$2.82

Beat

Revenue

$4.15B

vs Estimate

$4.10B

Beat

IQV Analyst Ratings

Consensus Rating

Buy

Based on 20 analysts

Strong Buy
4
Buy
17
Hold
2
Sell
0
Strong Sell
0

Average Price Target

$227.10

+21.9% upside

Low

$195.00

Current

$186.25

High

$287.00

IQV Analyst Estimates

Forward P/E: 13.16

Earnings Per Share (EPS) Estimates

Quarterly

PeriodLowAvgHigh# Analysts
Q1 2028N/A$3.53N/A7
Q2 2028N/A$3.72N/A6
Q3 2028N/A$3.95N/A6
Q4 2028N/A$4.41N/A7

Annual

PeriodLowAvgHigh# Analysts
FY 2027N/A$14.15N/A15
FY 2028N/A$15.73N/A8

Revenue Estimates

Quarterly

PeriodLowAvgHigh# Analysts
Q1 2028N/A$4.63BN/A7
Q2 2028N/A$4.76BN/A6
Q3 2028N/A$4.79BN/A6
Q4 2028N/A$4.97BN/A7

Annual

PeriodLowAvgHigh# Analysts
FY 2027N/A$18.25BN/A15
FY 2028N/A$19.24BN/A8

Source: FMP Analyst Consensus Estimates. Forward P/E calculated using average EPS estimate for the nearest fiscal year.

IQV Competitors' Key Metrics

StockMarket CapClose PricePrice ChangeTTM Total Return5Y CAGR10Y CAGR
1IQV$31.09B$186.25+1.39%+20.84%-4.90%+10.84%

About IQVIA Holdings Inc.

IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides a suite of cloud-native applications, complete with implementation services, and offers real-world data solutions designed to empower life sciences and healthcare providers in generating and disseminating evidence crucial for informed decision-making and improving patient outcomes. This division also delivers strategic and operational consulting, including advanced analytics support and outsourcing of commercial processes. Furthermore, it supplies country-level performance metrics detailing pharmaceutical sales, prescribing trends, medical treatments, and promotional activities across diverse channels like retail, hospital, and mail order, with data granularity extending to regional, postal code, and individual prescriber levels. Focusing on clinical trials, the Research & Development Solutions segment offers project management, clinical monitoring, broader clinical trial support, virtual trial capabilities, and strategic planning and design services. It also manages an extensive network of laboratory services, encompassing central, genomic, bioanalytical, ADME, discovery, vaccine, and biomarker analyses. The Contract Sales & Medical Solutions segment is responsible for engaging healthcare professionals and patients, alongside providing scientific strategy and medical affairs support. IQVIA's diverse clientele includes pharmaceutical, biotechnology, medical device and diagnostic, and consumer health companies. The company maintains a strategic collaboration with HealthCore, Inc. Founded in 1982, the firm was formerly known as Quintiles IMS Holdings, Inc. before rebranding as IQVIA Holdings Inc. in November 2017. Its headquarters are located in Durham, North Carolina.

Durham, NC
89,000 employees
Healthcare / Medical - Diagnostics & Research
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Ari Bousbib